Skip to content

The effect of Jacobson's progressive muscle relaxation on nausea and vomiting in pregnant women

The effect of progressive muscle relaxation on nausea and vomiting in pregnant women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180802040675N1
Enrollment
60
Registered
2018-08-16
Start date
2018-08-16
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting in pregnancy.

Interventions

Intervention 1: Intervention group: CD of progressive muscle relaxation is given to case group. After training, 2 times daily (morning & evening) for one month, case group perform relaxation and then

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Gestational age below 12 weeks based on the first day of the last menstruation or ultrasound 2- Single pregnancy 3- Reading and writing literacy 4- Pregnancy asked 5- Ability to use Compact Disc Muscle Relaxation 6- Lack of major physical and mental illness 7- Earning a score of less than 10, 14, 17 in response to the DOS-21 questionnaire in depression, anxiety and stress, respectively 8- Non-use of nausea and vomiting and anti-anxiety drugs 9- Non-use of fertility methods for pregnancy 10- No Smoking, Drug, and Alcohol 11- Failure to have significant stressful incidents during the past six months 12- Not using relaxation during pregnancy 13- The Rhodes Index score of 16-3

Exclusion criteria

Exclusion criteria: Unwilling to participate in the study

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting in pregnant women. Timepoint: Before intervention, two weeks after the intervention, four weeks after the intervention. Method of measurement: "Rhodes" Nausea and Vomiting Standard Test Questionnaire.

Secondary

MeasureTime frame
Anxiety, depression and stress in pregnant women. Timepoint: Before the intervention, two weeks after the intervention, four weeks after the intervention. Method of measurement: Depression, Anxiety and Stress Questionnaire DASS-21.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Shourgashti

Mashhad University of Medical Sciences

shourgashtiz931@mums.ac.ir+98 51 4335 0519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026